Registry of Lobbyists
Total Number of Communication Reports: 5
Monthly communication reports in the last 6 months: 0
| Subject matters | Details | Categories |
|---|---|---|
|
Economic Development, Health, Industry, Intellectual Property
|
To advocate for Entos' biomanufacturing facility in Edmonton Alberta for development of genetic medicines and vaccines in Canada including Entos' lead DNA vaccine program for COVID-19.
|
Policies or Program
|
End date of the last completed financial year: 2023-05-31
| Government Institution | Funding Received in Last Financial Year | Funding Expected in Current Financial Year |
|---|---|---|
| Government of Alberta | $15,500,000.00 | No |
| National Research Council (NRC) | $10,000,000.00 | Yes |
Address:
Unit 4550, 10230 Jasper Avenue
Edmonton, AB T5J 4P6
Canada
Telephone number:
780-862-7445
Web address:
https://www.entospharma.com/
John Lewis, Chief Executive Officer
Entos Pharmaceuticals is not a subsidiary of any other parent companies.
Entos Pharmaceuticals is not a coalition.
The activities of Entos Pharmaceuticals are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Entos Pharmaceuticals does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Farid Foroud | No public offices held
Firm: Global Public Affairs Inc.